NEW YORK (GenomeWeb) – Luminex said after the close of the market today that its fourth quarter revenues increased 5 percent year over year driven primarily by strong assay sales.
For the fourth quarter ended Dec. 31, 2014, Luminex reported $58.1 million in revenues compared to $55.2 million in the year-ago period and just below analysts' consensus estimate of $58.3 million.